125 related articles for article (PubMed ID: 16973375)
1. Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense.
Cerundolo V; de la Salle H
Semin Immunol; 2006 Dec; 18(6):330-6. PubMed ID: 16973375
[TBL] [Abstract][Full Text] [Related]
2. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice.
Garbi N; Tan P; Diehl AD; Chambers BJ; Ljunggren HG; Momburg F; Hämmerling GJ
Nat Immunol; 2000 Sep; 1(3):234-8. PubMed ID: 10973281
[TBL] [Abstract][Full Text] [Related]
3. MHC class I antigens, immune surveillance, and tumor immune escape.
Garcia-Lora A; Algarra I; Garrido F
J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
[TBL] [Abstract][Full Text] [Related]
4. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
[TBL] [Abstract][Full Text] [Related]
5. The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules.
Cabrera CM
Scand J Immunol; 2007 Jun; 65(6):487-93. PubMed ID: 17523940
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of tapasin in the peptide exchange on MHC class I molecules determined from kinetics simulation studies.
Schneeweiss C; Garstka M; Smith J; Hütt MT; Springer S
Mol Immunol; 2009 Jun; 46(10):2054-63. PubMed ID: 19362740
[TBL] [Abstract][Full Text] [Related]
8. Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJ; Offringa R; Ljunggren HG; van Hall T
Cancer Res; 2007 Sep; 67(18):8450-5. PubMed ID: 17875682
[TBL] [Abstract][Full Text] [Related]
9. Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A; Xu H; Yan W
Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
[TBL] [Abstract][Full Text] [Related]
10. HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
Chang CC; Campoli M; Ferrone S
Curr Opin Immunol; 2004 Oct; 16(5):644-50. PubMed ID: 15342012
[TBL] [Abstract][Full Text] [Related]
11. Viral interference with MHC class I antigen presentation pathway: the battle continues.
Ambagala AP; Solheim JC; Srikumaran S
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
[TBL] [Abstract][Full Text] [Related]
12. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides.
Hammer GE; Gonzalez F; James E; Nolla H; Shastri N
Nat Immunol; 2007 Jan; 8(1):101-8. PubMed ID: 17128277
[TBL] [Abstract][Full Text] [Related]
13. Role of tapasin in MHC class I antigen presentation in vivo.
Garbi N; Tan P; Momburg F; Hämmerling GJ
Adv Exp Med Biol; 2001; 495():71-8. PubMed ID: 11774611
[No Abstract] [Full Text] [Related]
14. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
15. MHC class I antigens and immune surveillance in transformed cells.
Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
[TBL] [Abstract][Full Text] [Related]
16. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.
Lybarger L; Wang X; Harris M; Hansen TH
Curr Opin Immunol; 2005 Feb; 17(1):71-8. PubMed ID: 15653314
[TBL] [Abstract][Full Text] [Related]
17. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer.
Wearsch PA; Cresswell P
Nat Immunol; 2007 Aug; 8(8):873-81. PubMed ID: 17603487
[TBL] [Abstract][Full Text] [Related]
18. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition.
Burrows JM; Bell MJ; Brennan R; Miles JJ; Khanna R; Burrows SR
Mol Immunol; 2008 Mar; 45(6):1818-24. PubMed ID: 17981331
[TBL] [Abstract][Full Text] [Related]
19. HLA-B polymorphisms and intracellular assembly modes.
Raghavan M; Geng J
Mol Immunol; 2015 Dec; 68(2 Pt A):89-93. PubMed ID: 26239417
[TBL] [Abstract][Full Text] [Related]
20. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome.
Pyzik M; Kielczewska A; Vidal SM
Semin Immunol; 2008 Dec; 20(6):331-42. PubMed ID: 18948016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
